PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine.  Led by a team from ...

A urine test is a simple yet informative diagnostic tool that can reveal a wide range of potential health issues, from ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have ...

A simple urine test that can assess the risk of kidney cancer recurrence at an early stage could spare patients from frequent ...

The technology presented in this study utilizes a paper test strip, a handheld spectrometer, and a small urine sample to identify pancreatic and prostate cancer quickly and in a non-invasive manner.

The work was supported by the International Prostate Cancer Foundation, the Johns Hopkins Kimmel Cancer Center (NIH grant # ...